Despite significant improvements in systemic chemotherapy during the past two decades, the prognosis of patients with advanced gastric and gastroesophageal junction adenocarcinoma remains poor. Because of molecular heterogeneity, it is essential to classify tumors based on the underlying oncogenic pathways and to develop targeted therapies acting on individual tumors. Unfortunately, although a number of molecular targets have been studied, very few of these agents can be used in a clinical setting. In this review, we summarize the available data on anti-angiogenic agents in advanced/metastatic gastric cancer.

Roviello, G., Petrioli, R., Marano, L., Polom, K.R., Marrelli, D., Perrella, A., et al. (2016). Angiogenesis inhibitors in gastric and gastroesophageal junction cancer. GASTRIC CANCER, 19(1), 31-41 [10.1007/s10120-015-0537-5].

Angiogenesis inhibitors in gastric and gastroesophageal junction cancer

ROVIELLO, GIANDOMENICO;PETRIOLI, ROBERTO;Marano, Luigi;POLOM, KAROL ROMAN;MARRELLI, DANIELE;PERRELLA, ARMANDO;ROVIELLO, FRANCO
2016-01-01

Abstract

Despite significant improvements in systemic chemotherapy during the past two decades, the prognosis of patients with advanced gastric and gastroesophageal junction adenocarcinoma remains poor. Because of molecular heterogeneity, it is essential to classify tumors based on the underlying oncogenic pathways and to develop targeted therapies acting on individual tumors. Unfortunately, although a number of molecular targets have been studied, very few of these agents can be used in a clinical setting. In this review, we summarize the available data on anti-angiogenic agents in advanced/metastatic gastric cancer.
2016
Roviello, G., Petrioli, R., Marano, L., Polom, K.R., Marrelli, D., Perrella, A., et al. (2016). Angiogenesis inhibitors in gastric and gastroesophageal junction cancer. GASTRIC CANCER, 19(1), 31-41 [10.1007/s10120-015-0537-5].
File in questo prodotto:
File Dimensione Formato  
Angiogenesis inhibitors in gastric and gastroesophageal junction cancer.pdf

non disponibili

Tipologia: PDF editoriale
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 683.9 kB
Formato Adobe PDF
683.9 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11365/995141
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo